Ridker, P. Et Al. 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine , vol.377, no.12 , 1119-1131.

Ridker, P., Everett, B., Thuren, T., MacFadyen, J., Chang, W., Ballantyne, C., ... Fonseca, F.(2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine , vol.377, no.12, 1119-1131.

Ridker, P.M. Et Al. "Antiinflammatory therapy with canakinumab for atherosclerotic disease," New England Journal of Medicine , vol.377, no.12, 1119-1131, 2017

Ridker, P.M. Et Al. "Antiinflammatory therapy with canakinumab for atherosclerotic disease." New England Journal of Medicine , vol.377, no.12, pp.1119-1131, 2017

Ridker, P. Et Al. (2017) . "Antiinflammatory therapy with canakinumab for atherosclerotic disease." New England Journal of Medicine , vol.377, no.12, pp.1119-1131.

@article{article, author={P.M. Ridker Et Al. }, title={Antiinflammatory therapy with canakinumab for atherosclerotic disease}, journal={New England Journal of Medicine}, year=2017, pages={1119-1131} }